EV/EBIT společnosti Edesa Biotech
Jaká je hodnota metriky EV/EBIT společnosti Edesa Biotech?
Hodnota metriky EV/EBIT společnosti Edesa Biotech, Inc. je N/A
Jaká je definice metriky EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Edesa Biotech
Čemu se věnuje společnost Edesa Biotech?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Firmy s metrikou ev/ebit podobnou společnosti Edesa Biotech
- Hodnota metriky EV/EBIT společnosti Telesis Bio Inc je N/A
- Hodnota metriky EV/EBIT společnosti Iterum Therapeutics Plc je N/A
- Hodnota metriky EV/EBIT společnosti Nuformix Plc je N/A
- Hodnota metriky EV/EBIT společnosti Alvo Minerals Ltd je N/A
- Hodnota metriky EV/EBIT společnosti NCS Multistage Inc je N/A
- Hodnota metriky EV/EBIT společnosti DarioHealth Corp je N/A
- Hodnota metriky EV/EBIT společnosti Edesa Biotech je N/A
- Hodnota metriky EV/EBIT společnosti Eupraxia Pharmaceuticals je N/A
- Hodnota metriky EV/EBIT společnosti QDM International je N/A
- Hodnota metriky EV/EBIT společnosti Orion Nutraceuticals Inc je N/A
- Hodnota metriky EV/EBIT společnosti Hopefield Ventures Inc je N/A
- Hodnota metriky EV/EBIT společnosti Delta Drone SA je N/A
- Hodnota metriky EV/EBIT společnosti Sable Resources je N/A